Beneficial effects of olmesartan, a novel angiotensin II receptor type 1 antagonist, upon acute autoimmune myocarditis

By Nimata Masaomi   Kishimoto Chiharu   Yuan Zuyi   Shioji Keisuke  

Molecular and Cellular Biochemistry, Vol. 259, Iss. 1-2, 2004-04 ,pp. : 217-222

Springer Publishing Company

Access to resources Recommend Favorite

The Angiotensin-II Receptor Antagonist, Losartan, Inhibits LDL Lipid Peroxidation and Atherosclerosis in Apolipoprotein E-Deficient Mice

By Keidar S.   Attias J.   Smith J.   Breslow J.L.   Hayek T.  

Biochemical and Biophysical Research Communications, Vol. 236, Iss. 3, 1997-07 ,pp. : 622-625

Elsevier

Access to resources Recommend Favorite

Pharmacokinetics, metabolism and pharmacodynamic s of a benzimidazole angiotensin II type 1 receptor antagonist in the beagle dog and cynomologus monkey

By Kakiki M.   Ishihara H.  

Xenobiotica, Vol. 28, Iss. 1, 1998-01 ,pp. : 77-91

Informa Healthcare

Access to resources Recommend Favorite

Identification of cytochrome P450 forms involved in the 4-hydroxylation of valsartan, a potent and specific angiotensin II receptor antagonist, in human liver microsomes

By Nakashima A.   Kawashita H.   Masuda N.   Saxer C.   Niina M.   Nagae Y.   Iwasaki K.  

Xenobiotica, Vol. 35, Iss. 6, 2005-06 ,pp. : 589-602

Informa Healthcare

Access to resources Recommend Favorite

The frequency of factor V Leiden mutation, ACE gene polymorphism, serum ACE activity and response to ACE inhibitor and angiotensin II receptor antagonist drugs in Iranians type II diabetic patients with microalbuminuria

By Rahimi Zohreh   Felehgari Vahid   Rahimi Mehrali   Mozafari Hadi   Yari Kheirollah   Vaisi-Raygani Asad   Rezaei Mansour   Malek-Khosravi Shohreh   Khazaie Habibolah  

Molecular Biology Reports, Vol. 38, Iss. 3, 2011-03 ,pp. : 2117-2123

Springer Publishing Company

Access to resources Recommend Favorite